XTX Topco Ltd Acquires New Position in Sensus Healthcare, Inc. (NASDAQ:SRTS)

XTX Topco Ltd bought a new position in shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 17,911 shares of the company’s stock, valued at approximately $95,000. XTX Topco Ltd owned 0.11% of Sensus Healthcare as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Renaissance Technologies LLC grew its position in shares of Sensus Healthcare by 34.4% during the 2nd quarter. Renaissance Technologies LLC now owns 391,534 shares of the company’s stock worth $2,087,000 after buying an additional 100,294 shares during the period. Dimensional Fund Advisors LP increased its position in shares of Sensus Healthcare by 128.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 166,590 shares of the company’s stock valued at $888,000 after buying an additional 93,511 shares in the last quarter. Sachetta LLC raised its stake in Sensus Healthcare by 12.9% during the 2nd quarter. Sachetta LLC now owns 118,354 shares of the company’s stock worth $631,000 after buying an additional 13,544 shares during the period. Acadian Asset Management LLC lifted its holdings in Sensus Healthcare by 578.6% during the second quarter. Acadian Asset Management LLC now owns 45,124 shares of the company’s stock worth $239,000 after acquiring an additional 38,474 shares in the last quarter. Finally, Chapin Davis Inc. acquired a new position in Sensus Healthcare in the second quarter valued at about $53,000. Institutional investors own 25.30% of the company’s stock.

Sensus Healthcare Trading Up 1.7 %

SRTS stock opened at $5.90 on Wednesday. The stock has a 50-day moving average price of $6.21 and a two-hundred day moving average price of $5.23. Sensus Healthcare, Inc. has a 1 year low of $1.79 and a 1 year high of $7.18. The stock has a market cap of $96.72 million, a PE ratio of 20.34 and a beta of 1.05.

Sensus Healthcare (NASDAQ:SRTS) last announced its earnings results on Thursday, August 8th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.07. Sensus Healthcare had a return on equity of 13.46% and a net margin of 18.27%. The business had revenue of $9.24 million for the quarter, compared to analyst estimates of $7.00 million. During the same quarter last year, the firm earned ($0.02) EPS. On average, analysts forecast that Sensus Healthcare, Inc. will post 0.36 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

SRTS has been the topic of several recent analyst reports. HC Wainwright reiterated a “buy” rating and set a $10.00 price objective on shares of Sensus Healthcare in a report on Monday, August 12th. Roth Capital upgraded shares of Sensus Healthcare to a “strong-buy” rating in a report on Friday, July 12th.

About Sensus Healthcare

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.